Beijing Wantai Biological Pharmacy Enterprise

Founded in 1991, Wantai BioPharm develops in vitro diagnostic technologies and vaccines for infectious disease detection, disease prevention and public health applications. The company combines expertise in immunodiagnostics, molecular testing and vaccine development, supporting laboratories, healthcare providers and research institutions worldwide. Its portfolio spans chemiluminescence assays, enzyme immunoassays, colloidal gold rapid tests, molecular diagnostics, clinical biochemistry systems and quality control materials. Through its collaboration with the National Institute of Diagnostics and Vaccine Development (NIDVD), Wantai supports the translation of diagnostic and vaccine research into products used across infectious disease surveillance, clinical testing and preventive healthcare.

Europa Biosite’s subsidiaries distribute for Beijing Wantai in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and the United Kingdom.